Baqsimi 3 MG spray two packs
Ended Awarded Last action
- Contract number
- SPE2DR26F9HS4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,227
Award facts
- Contract value 100% obligated
- $37,227.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $37,227.40 to AmerisourceBergen Drug Corp for Baqsimi 3 mg spray two-packs, with a completion date of December 30, 2025. This is a firm fixed-price delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
Baqsimi is a glucagon nasal spray used for emergency treatment of severe hypoglycemia in individuals with diabetes. This delivery order represents a routine replenishment of critical medical supplies through AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA. The company's federal contract portfolio demonstrates extensive experience fulfilling Defense Health Agency and other federal healthcare system requirements across multiple therapeutic domains, including specialty medications, generic drugs, and medical devices. The SPE2DX contract exemplifies the agency's strategy to leverage prime vendor arrangements for efficient, flexible pharmaceutical distribution to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F9HS4?
SPE2DR26F9HS4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9HS4 worth?
The government has obligated $37,227 on SPE2DR26F9HS4.
Is contract SPE2DR26F9HS4 an order under another contract?
Yes. SPE2DR26F9HS4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HS4 competed?
The extent of competition for SPE2DR26F9HS4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award